Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer

被引：0
作者：
Makoto Natsume
Takaya Shimura
Hiroyasu Iwasaki
Yusuke Okuda
Mika Kitagawa
Yasuyuki Okamoto
Kazuki Hayashi
Hiromi Kataoka
机构：
[1] Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and Metabolism
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Angiogenesis; Biomarker; Gastric cancer; PlGF; Ramucirumab; VEGF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1037 / 1046
页数：9
相关论文
共 50 条
  • [41] Impact of Second-line Chemotherapy on Prognosis: Response of Advanced Gastric Cancer to Taxanes Plus Ramucirumab
    Masuda, Yuka
    Kananazawa, Yoshikazu
    Matsuno, Kunihiko
    Kakinuma, Daisuke
    Sakurazawa, Nobuyuki
    Ando, Fumihiko
    Hagiwara, Nobutoshi
    Nomura, Tsutomu
    Kato, Shunji
    Yoshiyuki, Toshiro
    Yoshida, Hioshi
    ANTICANCER RESEARCH, 2022, 42 (03) : 1599 - 1605
  • [42] Vascular Endothelial Growth Factor as a Predictive and Prognostic Biomarker for Multiple Sclerosis
    Harandi, Ali Amini
    Siavoshi, Fatemeh
    Barough, Siavash Shirzadeh
    Harandi, Asghar Amini
    Pakdaman, Hossein
    Sahraian, Mohammad Ali
    Fathtabar, Zahra
    Mohammadi, Faezeh
    Karamiani, Faezeh
    Ardehali, Seyed Hossein
    NEUROIMMUNOMODULATION, 2022, 29 (04) : 476 - 485
  • [43] Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer
    Tokumaru, Shigeo
    Koizumi, Tomonobu
    Sekino, Yasushi
    Takeuchi, Nobumichi
    Nakata, Shinji
    Miyagawa, Yusuke
    Kitazawa, Masato
    Muranaka, Futoshi
    Nakamura, Satoshi
    Koyama, Makoto
    Yamamoto, Yuta
    Ehara, Takehito
    Hondo, Nao
    Soejima, Yuji
    ONCOLOGY, 2021, 99 (10) : 632 - 640
  • [44] A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites
    Matsumoto, Hiroshi
    Kawazoe, Akihito
    Shimada, Kaoru
    Fukuoka, Shota
    Kuboki, Yasutoshi
    Bando, Hideaki
    Kojima, Takashi
    Ohtsu, Atsushi
    Yoshino, Takayuki
    Doi, Toshihiko
    Shitara, Kohei
    BMC CANCER, 2018, 18
  • [45] Placental growth factor as a sensitive biomarker for vascular cognitive impairment
    Hinman, Jason D.
    Elahi, Fanny
    Chong, Davis
    Radabaugh, Hannah
    Ferguson, Adam
    Maillard, Pauline
    Thompson, Jeffrey F.
    Rosenberg, Gary A.
    Sagare, Abhay
    Moghekar, Abhay
    Lu, Hanzhang
    Lee, Tiffany
    Wilcock, Donna
    Satizabal, Claudia L.
    Tracy, Russell
    Seshadri, Sudha
    Schwab, Kristin
    Helmer, Karl
    Singh, Herpreet
    Kivisakk, Pia
    Greenberg, Steve
    DeCarli, Charlie
    Kramer, Joel
    ALZHEIMERS & DEMENTIA, 2023, 19 (08) : 3519 - 3527
  • [46] A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites
    Hiroshi Matsumoto
    Akihito Kawazoe
    Kaoru Shimada
    Shota Fukuoka
    Yasutoshi Kuboki
    Hideaki Bando
    Takashi Kojima
    Atsushi Ohtsu
    Takayuki Yoshino
    Toshihiko Doi
    Kohei Shitara
    BMC Cancer, 18
  • [47] Efficacy and Safety of Ramucirumab/nab-paclitaxel for Previously Treated Advanced Gastric Cancer in Community Hospitals
    Hashida, Shinsuke
    Tanaka, Norimitsu
    Takahashi, Yuta
    Onoda, Yuji
    Colvin, Hugh Shunsuke
    Ohashi, Ryuichiro
    Okamoto, Kunio
    ACTA MEDICA OKAYAMA, 2021, 75 (02) : 133 - 138
  • [48] The clinical position of ramucirumab-containing regimens for advanced gastric cancer: a review of clinical trial data
    Iwasa, Satoru
    Bando, Hideaki
    Piao, Yongzhe
    Yoshizawa, Kenichi
    Yamaguchi, Kensei
    FUTURE ONCOLOGY, 2022, 18 (21) : 2709 - 2722
  • [49] Biomarker-oriented chemo-immunotherapy for advanced gastric cancer
    Kono, Koji
    Nakajima, Shotaro
    Mimura, Kosaku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (7) : 865 - 872
  • [50] Ramucirumab efficacy in first-line gastric and esophageal cancer treatment
    Longo, Federico
    Reguera, Pablo
    Carrato, Alfredo
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S617 - S621
12345